myocardialinfarction_df: Streptokinase Therapy in AMI

In CardioDataSets: A Comprehensive Collection of Cardiovascular and Heart Disease Datasets

Streptokinase Therapy in AMI

Description

This dataset, myocardialinfarction_df, is a data frame containing information from 33 clinical trials comparing intravenous streptokinase versus placebo or no therapy in patients hospitalized for acute myocardial infarction. It includes data on treatment outcomes between intervention and control groups.

Usage

data(myocardialinfarction_df)

Format

A data frame with 33 observations and 6 variables:

trial

Trial identifier (character vector)

year

Year of publication (integer vector)

ai

Number of events in treatment group (integer vector)

n1i

Total number of participants in treatment group (integer vector)

ci

Number of events in control group (integer vector)

n2i

Total number of participants in control group (integer vector)

Details

The dataset name has been kept as 'myocardialinfarction_df' to avoid confusion with other datasets in the R ecosystem. This naming convention helps distinguish this dataset as part of the CardioDataSets package and assists users in identifying its specific characteristics. The suffix 'df' indicates that the dataset is a standard data frame. The original content has not been modified in any way.

Source

Data taken from the metadat package version 1.2-0. Original publication: Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992). "Cumulative meta-analysis of therapeutic trials for myocardial infarction." New England Journal of Medicine, 327(4):248-254.

CardioDataSets documentation built on June 8, 2025, 10:59 a.m.